Cabaletta Bio, Inc. (CABA) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 10 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for CABA is $16.33, representing a +400.9% upside from the current price of $3.26. Price targets range from a low of $3.00 to a high of $32.00.
